{
  "docId": "019de513-bbaf-7632-8c51-2e65d00dc762",
  "docSlug": "d61504792622527e2ff1c803565a1f5e",
  "documentTitle": "Bausch+Lomb | Results Presentation Deck | 42 slides",
  "authorId": "bausch-lomb",
  "authorName": "Bausch + Lomb",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 24,
  "pageCount": 42,
  "prevPage": 23,
  "nextPage": 25,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de513-bbaf-7632-8c51-2e65d00dc762/24",
  "deckHref": "/decks/019de513-bbaf-7632-8c51-2e65d00dc762",
  "deckJsonHref": "/decks/019de513-bbaf-7632-8c51-2e65d00dc762.json",
  "deckAnchorHref": "/decks/019de513-bbaf-7632-8c51-2e65d00dc762#slide-24",
  "components": [
    {
      "bbox": {
        "h": 0.03,
        "w": 0.359,
        "x": 0.159,
        "y": 0.918
      },
      "kind": "source-note",
      "text": "1. See slide 1 for further information on forward-looking statements.\n2. Exclusive licensing agreement with BHVI.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "790fdfc1-7a84-49f7-8e6c-77cacb98d2ba",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.46,
        "w": 0.869,
        "x": 0.045,
        "y": 0.248
      },
      "kind": "table",
      "text": "Vision Care\nProduct\nSiHy Daily\nLacelle® colored contact lenses\nBiotrue® Hydration Plus Multi-purpose Solution\nBiotrue® PF Contact Lens Rehydrating Drops (Multidose & Single Dose Use)\nLUMIFY® Line Extensions\nMyopia control contact lens2\nStatus\nLaunched in ~25 countries\nApproved in Japan\nApproved (US FDA, Health Canada, NMPA/ China)\nDesign transfer and Commercialization Readiness stage\nPhase 3 study in progress\nMyopia control contact lens design licensed from BHVI\nUpcoming Milestone\nLaunching SVS into more countries in 2022; Multi-focal and toric launch coming 2022-2023\nNew range of Daily Disposable cosmetic lens launching in Japan summer 2022\nU.S. launch ongoing; Canada launch expected 2H22 and China launch expected 1H23\nU.S. FDA submission expected 2022, launch mid-2023\nOne phase 3 clinical study started. Additional studies to start in 2H22\nGlobal Clinical Strategy updated and finalizing clinical trial design",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d6ef643e-e1c2-476d-8529-e4b2da2dc599",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.029,
        "w": 0.429,
        "x": 0.045,
        "y": 0.08
      },
      "kind": "title",
      "text": "Pipeline and Upcoming Milestones¹",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1000945a-a524-4917-829d-08d5a784221a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 24,
      "from": 23,
      "beatId": "f81e2cbb-806b-4ab4-a783-f0c0f229e3e4",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Market Size",
      "beatSlug": "sequoia-pitch-market-size",
      "evidence": "Slides 23-24 provide market analysis and pipeline information",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}